Free Trial

Scotiabank Comments on Savaria's FY2027 Earnings (TSE:SIS)

Savaria logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Scotiabank raised its FY2027 EPS forecast for Savaria to C$1.52 from C$1.50; the article reports a current-year consensus estimate of C$1.20.
  • Savaria reported quarterly EPS of C$0.32 and revenue of C$245.03 million, with a 9.44% net margin and 13.59% return on equity.
  • Analyst sentiment is broadly positive: the stock has a consensus “Buy” rating and an average price target of C$34.35.
  • MarketBeat previews top five stocks to own in December.

Savaria Co. (TSE:SIS - Free Report) - Scotiabank raised their FY2027 earnings per share estimates for shares of Savaria in a note issued to investors on Wednesday, November 11th. Scotiabank analyst J. Goldman now forecasts that the company will earn $1.52 per share for the year, up from their previous estimate of $1.50. The consensus estimate for Savaria's current full-year earnings is $1.20 per share.

Savaria (TSE:SIS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported C$0.32 EPS for the quarter. Savaria had a net margin of 9.44% and a return on equity of 13.59%. The company had revenue of C$245.03 million during the quarter.

Other equities analysts also recently issued reports about the stock. Desjardins started coverage on shares of Savaria in a report on Wednesday, November 4th. They set a "moderate buy" rating on the stock. TD boosted their target price on Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a research report on Friday, August 7th. TD Securities upgraded Savaria to a "strong-buy" rating in a research report on Friday, July 24th. ATB Cormark Capital Markets upped their target price on Savaria from C$35.00 to C$38.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Finally, Ventum Financial set a C$34.50 price objective on Savaria and gave the company a "buy" rating in a report on Thursday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating and nine have assigned a Buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of C$34.35.

Get Our Latest Stock Report on Savaria

Savaria Stock Performance

Shares of SIS opened at C$29.86 on Monday. Savaria has a twelve month low of C$20.72 and a twelve month high of C$31.95. The company has a current ratio of 1.67, a quick ratio of 0.91 and a debt-to-equity ratio of 26.86. The company's fifty day simple moving average is C$29.36 and its 200-day simple moving average is C$28.39. The company has a market cap of C$2.15 billion, a P/E ratio of 23.70, a P/E/G ratio of 42.72 and a beta of 0.58.

Insider Transactions at Savaria

In other Savaria news, insider Jean-Philippe De Montigny sold 10,000 shares of the company's stock in a transaction dated Monday, September 21st. The shares were sold at an average price of C$29.21, for a total value of C$292,100.00. Following the transaction, the insider directly owned 82,560 shares in the company, valued at C$2,411,577.60. This represents a 10.80% decrease in their position. Also, Director Les Teague sold 5,000 shares of the company's stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of C$29.52, for a total transaction of C$147,600.00. Company insiders own 17.45% of the company's stock.

About Savaria

(Get Free Report)

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

See Also

Earnings History and Estimates for Savaria (TSE:SIS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Savaria Right Now?

Before you consider Savaria, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.

While Savaria currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines